Document is current

Any future updates will be listed below

Cetuximab plus platinum-based chemotherapy in head and neck squamous cell carcinoma: a randomized, double-blind safety study comparing cetuximab produced from two manufacturing processes using the EXTREME study regimen

Crossref DOI link: https://doi.org/10.1186/s12885-016-2064-0

Published Online: 2016-01-14

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark